BioNtech vaccine approval by October 2020 looks 'so far so good': Wolfe Research

German drugmaker BioNtech and U.S. firm Pfizer are on track to seek approval over a jointly-developed potential coronavirus vaccine with the U.S. Food and Drug Administration by October 2020, says Akash Tewari of Wolfe Research. Obtaining full approval, which has a higher regulatory bar, is likely to occur in the first half of 2021, he adds.
Tue, Aug 11 202010:33 PM EDT